WHO issues emergency use listing for Covaxin

This is the eighth Covid-19 vaccine to receive Emergency Use Listing

Lancet endorses Sputnik Light for safety and immune response

Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries

Covaxin shelf-life extended to 12 months from the date of manufacture

This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO

Transforming Healthcare Through AI

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.

MSD and MPP sign licensing agreement to make molnupiravir affordable

In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.

Ocugen submits IND application with U.S. FDA for Covaxin phase 3 trial

The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population

Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22

Cipla has reported consolidated financial results for the period ended September 30, 2021

Medwiki’s online video library aims to help understand medicines better

It answers the most basic questions from a patient’s perspective

PLI scheme has the potential to make India a pharma hub: Dr Mandaviya

FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year